FCRL6 and blood disease: A recent study also showed a significant decrease in the FCRL6 gene expression in peripheral T cells of patients with certain autoimmune and blood diseases [9], and its upregulation in patients with late stage HIV infection, suggesting FCRL6’s inhibitory potential in the modulation of immune effector functions in infectious diseases.